Unknown

Dataset Information

0

Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations.


ABSTRACT: The components of the Switch/Sucrose non-fermentable (SWI/SNF) complex are mutated in approximately 20% of human cancers. The A/T-rich interacting domain 1A (ARID1A) subunit has one of the highest mutation rates. Most notably, ARID1A is mutated in over 50% of ovarian clear cell carcinomas (OCCCs). We reported that inhibition of enhancer of zeste homology 2 (EZH2) is synthetically lethal in ARID1A-mutated OCCC.

SUBMITTER: Bitler BG 

PROVIDER: S-EPMC4845188 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

Similar Datasets

2023-05-10 | PXD040422 | Pride
| S-EPMC4522155 | biostudies-literature
| S-EPMC6036828 | biostudies-literature
| S-EPMC8172121 | biostudies-literature
| S-EPMC8571039 | biostudies-literature
| S-EPMC3076894 | biostudies-literature
| S-EPMC6521555 | biostudies-literature
| S-EPMC4181630 | biostudies-other
2022-09-02 | PXD032355 | Pride
| S-EPMC4352133 | biostudies-literature